NP90219b Leuprorelin (Prostap®)

Concepts

• edinburgh
• pharmaceutical products
• prostap®
• np90219b leuprorelin
• leuprorelin
• prostap
• np90219b
• participating authorities
• nhs scotland
• scotland

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Description

The supply of Leuprorelin (Prostap®) to NHS Scotland.

Total Quantity or Scope

The Framework Agreement is for the supply of Leuprorelin (Prostap®) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant. The Framework Participant is required to supply Goods to the designated delivery points throughout Scotland for use by Participating Authorities.

Award Detail

CPV Codes

• 33600000 - Pharmaceutical products

Legal Justification

This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value of the Framework Agreement referred to in Section II.1.7 and V.2.4 covers the twelve (12) month duration of the proposed modification period of the Framework Agreement. (SC Ref:781898)